General Review of Clinical Trial Environment in Japan ver.2016
SKU:
$480.00
$480.00
per item
- Summary
- Definition
- Regulations related to clinical development
- Trend - clinical development in Japan
- Challenges when conducting clinical trials in Japan
- Outsourcing trend
- Major CRO players
- Situations in other Asian countries
- Future prospect
While he number of clinical trials in Japan had been flat for la long time, it has been slightly increasing in the past few years.
The number of multinational studies has been increasing steadily, while local projects has been decreasing contrarily.
It is not quite easy to conduct clinical trials in Japan due to several factors; less priority on clinical research for sites and investigators, less financial incentive for investigators and patients, and local barriers such as business practices and language. Japanese government has been trying to improve the situation,
The government has been trying to improve the environment for clinical trials in Japan, and we are seeing some improvement, especially increasing number of clinical trials.
However, if we look at other Asian countries such as China and Korea, their move is much faster than Japan, and the clinical trial markets have been growing significantly.
The government and the industry need to take further measure to improve the environment of clinical trial in Japan.
The number of multinational studies has been increasing steadily, while local projects has been decreasing contrarily.
It is not quite easy to conduct clinical trials in Japan due to several factors; less priority on clinical research for sites and investigators, less financial incentive for investigators and patients, and local barriers such as business practices and language. Japanese government has been trying to improve the situation,
The government has been trying to improve the environment for clinical trials in Japan, and we are seeing some improvement, especially increasing number of clinical trials.
However, if we look at other Asian countries such as China and Korea, their move is much faster than Japan, and the clinical trial markets have been growing significantly.
The government and the industry need to take further measure to improve the environment of clinical trial in Japan.